Latest filing published 22 Sept 2021 for Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.), €28k.
Robert David Sindelar discloses dealings in Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) to SEDI. Over a trading history stretching from 21 March 2018 to 21 July 2021, the count stands at 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 22 September 2021, reports an option exercise of €28k in Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.). Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations